Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 22, 2024MedCommOpen Access

Targeting polymorphonuclear myeloid‐derived suppressor cells in the immunosuppressive tumor microenvironment for cancer immunotherapy

View Full Paper
Ask AI
Bookmark
Share

Authors

SLShiqi LiXLXinghua Long

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Li et al. (2024) studied this question.

synapsesocial.com/papers/68e63afdb6db6435875cd78ahttps://doi.org/10.1002/mco2.602
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Targeting CD300ld to normalize the tumor microenvironment: an emerging insight in cancer immunotherapy2024 · 3 citations
  2. 2Role of Myeloid-Derived Suppressor Cells in Tumor Immunotherapy2011 · 32 citations
  3. 3Targeting myeloid cells to improve cancer immune therapy2025 · 23 citations
  4. 4Myeloid-Derived Suppressor Cells: Orchestrators of Tumor Immune Evasion and Therapeutic Vulnerabilities2025 · 13 citations
  5. 5Targeting MDSCs in cancer: emerging immunotherapeutic and metabolic strategies.2026